Progenity Announces Encouraging Preclinical Data Supporting the Potential of the Company’s Oral Drug Delivery System in Targeting the Colon
SAN DIEGO, Nov. 06, 2020 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company…
Month: November 2020
Aleafia Health Successful Outdoor Harvest Accelerates Product Portfolio Expansion
Aleafia Health Port Perry Outdoor cannabis cultivation. TORONTO, Nov. 06, 2020 (GLOBE NEWSWIRE) — Aleafia…
Apollomics, Inc. Closes $124 Million Series C Financing
– Financing led by Ping An Capital – – Phase 2 SPARTA Trial for APL-101…
Matinas BioPharma Reports Third Quarter 2020 Financial Results and Operational Highlights
EnACT study of MAT2203 in cryptococcal meningitis received unanimous Data and Safety Monitoring Board (DSMB)…
FibroGen to Present at Upcoming Investor Conferences
SAN FRANCISCO, Nov. 06, 2020 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) today announced that…
Jounce Therapeutics Reports Third Quarter 2020 Financial Results
-On track to begin enrollment in the Phase 1 trial for JTX-8064 by year-end 2020-…
Adicet Bio to Participate in Upcoming Investor Conferences
MENLO PARK, Calif. and BOSTON, Nov. 06, 2020 (GLOBE NEWSWIRE) — Adicet Bio, Inc. (Nasdaq:…
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2020
Reports Net Revenues of $83.4 Million for the Three Months Ended September 30, 2020 RANCHO…
Industry Veteran Susan Benton Joins the Ocuphire Pharma Board of Directors
FARMINGTON HILLS, Mich., Nov. 06, 2020 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc., a clinical-stage ophthalmic…
Assertio Reports Third Quarter 2020 Financial Results
Reported Net Product Sales of $34.3 Million Non-GAAP Net Product Sales of $33.7 Million; Increased…
Basilea announces approval of antibiotic Zevtera® in China to treat community-acquired pneumonia and hospital-acquired pneumonia
National Medical Products Administration (NMPA) granted Drug Approval License to Basilea’s partner CR Gosun Basilea…
Novartis provides update on CAN-COVID trial in hospitalized patients with COVID-19 pneumonia and cytokine release syndrome (CRS)
The Phase III trial investigating canakinumab plus standard of care (SoC) did not meet its…
Ocuphire Pharma Completes Transactions and Begins Trading on Nasdaq as OCUP
Merger completed with Rexahn Pharmaceuticals creating a Nasdaq-listed Biopharmaceutical Company Focused on Advancing Ocuphire’s Late-Stage…
Osmotica Pharmaceuticals plc to Provide Third Quarter 2020 Business and Financial Update on November 10, 2020
BRIDGEWATER, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or…
Genocea to Host Investor Call Highlighting New GEN-009 Clinical and Immunogenicity Data to be Presented at Virtual SITC 2020
Call scheduled for November 9th at 8:30 a.m. EST CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE…
Chinook Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
Upon closing of the merger with Aduro on October 5th, Chinook had approximately $290 million…
Kane Biotech Enters into Credit Facility with Pivot Financial
WINNIPEG, Manitoba, Nov. 05, 2020 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane Biotech”)…
Cellectis Provides Business Update and Reports Financial Results for Third Quarter and First Nine Months 2020
Sponsored program at ASH 2020 – Oral presentation of initial data for BALLI-01 clinical trial…
ERYTECH Provides Business Update and Reports Financial Results for the Third Quarter of 2020
Conference call and webcast on Friday, November 6 at 2:30 pm CET/8:30 am ET TRYbeCA-1…
vTv Therapeutics Announces 2020 Third Quarter Financial Results and Update
HIGH POINT, N.C., Nov. 05, 2020 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq:VTVT) today reported…